China Health Industries Holdings (China Health Industries Holdings) Debt-to-Equity : -2.47 (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is China Health Industries Holdings Debt-to-Equity?

China Health Industries Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $5.65 Mil. China Health Industries Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. China Health Industries Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-2.29 Mil. China Health Industries Holdings's debt to equity for the quarter that ended in Dec. 2023 was -2.47.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for China Health Industries Holdings's Debt-to-Equity or its related term are showing as below:

CHHE' s Debt-to-Equity Range Over the Past 10 Years
Min: -2.47 Med: 0.15 Max: 0.19
Current: -2.47

During the past 13 years, the highest Debt-to-Equity Ratio of China Health Industries Holdings was 0.19. The lowest was -2.47. And the median was 0.15.

CHHE's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.29 vs CHHE: -2.47

China Health Industries Holdings Debt-to-Equity Historical Data

The historical data trend for China Health Industries Holdings's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Industries Holdings Debt-to-Equity Chart

China Health Industries Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-Equity

Get a 7-Day Free Trial

0.19

0.18

0.16

0.13

China Health Industries Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.14	0.14	0.13	0.13	-2.47

Competitive Comparison of China Health Industries Holdings's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China Health Industries Holdings's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where China Health Industries Holdings's Debt-to-Equity falls into.

China Health Industries Holdings Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

China Health Industries Holdings's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.154	+	0)	/	39.11
	=	0.13

China Health Industries Holdings's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(5.652	+	0)	/	-2.29
	=	-2.47

China Health Industries Holdings (OTCPK:CHHE) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

China Health Industries Holdings Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of China Health Industries Holdings's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

China Health Industries Holdings (China Health Industries Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Health Industries Holdings Inc (OTCPK:CHHE) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

3199-1 Longxiang Road, Songbei District, Heilongjiang Province, Harbin, CHN, 150028

Website

http://www.chinahealthindustries.com

China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.

Executives

Sun Xin	director, 10 percent owner, officer: CEO, CFO and Treasurer	NO 168 BINBEI STREET, SONBEI DISTRICT, HARBIN, HEI LONG JIANG F4 150000
Hall E Ewing	director, officer: Secretary	2737 W BASELINE RD 22, TEMPE AZ 85283
Jack C Robinson	director	16304 E COUNTRY SHADOW CT, LILBEAT AZ 85297
Teri S Foster	director	402 CANDOVER COURT, KATY TX 77450
Brian Lee Hahn	director, officer: COO	422 LAMONT TERRACE, BUFFALO GROVE IL 60089
Dennis Mckee	10 percent owner	3522 DOHERTY PLACE, KATY TX 77449
Thomas Allen Bontems	10 percent owner, officer: President, CEO, CFO and, other: Secretary	1808 S. 1ST AVENUE, PHONEIX AZ 85003

China Health Industries Holdings (China Health Industries Holdings) Headlines

No Headlines